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Abstract 
Purpose: To investigate the cognition-enhancing effects of aqueous extract of Indigofera tinctoria Linn 
(ITE, Fabaceae) in experimental amnesic mice. 
Methods: Scopolamine (2 mg/kg, i.p.) was used to induce amnesia in mice. The cognitive-enhancing 
activity of the ITE (5, 10 and 20 μg/mL) was studied by passive avoidance response, elevated plus 
maze and Y-maze behavioral paradigm in normal and scopolamine-induced amnesic mice. Antioxidant 
activities were also determined based on the ability of ITE to inhibit lipid peroxide, superoxide and 
hydroxyl radicals. 
Results: Scopolamine-induced cognitive deficits were significantly reversed by ITE (p < 0.001 at 20 
mg/kg) in a dose-dependent fashion in all the behavioral paradigms tested. Furthermore, ITE dose-
dependently scavenged lipid peroxide, superoxide and hydroxyl free radicals with 50 % inhibition 
concentration (IC50) of 7.28 ± 0.37, 5.25 ± 0.28 and 7.62 ± 0.43 μg/mL, respectively.  
Conclusion: ITE possesses cognitive-enhancing properties in amnesic mice due to its potent 
antioxidant action. 
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Cognition in a broad sense means the ability of 
the brain to encode, store and retrieve 
information [1]. The hippocampus contains the 
neural circuitry crucial for cognitive functions 
such as learning and memory, and intellectual 
aspects of mental functioning [2,3].Cognitive 
dysfunction, a major health problem in recent 
times can negatively affect learning and memory 
skills of individuals leading to the pathogenesis of 
various neurodegenerative disorders [4,5]. 
Mounting evidence suggests that oxidative 
damage in the central nervous system (CNS) is 
likely the cause of cognitive dysfunction.  In 
particular, brain is believed to be vulnerable to 
oxidative stress due to a relatively high rate of 
oxygen free radical generation, with relatively 
reduced levels of antioxidative defenses [6,7].  
 
Various antioxidant supplements and 
phytochemical components might be helpful for 
preserving brain functions and forestalling 
neurodegeneration [8]. Thus, agents that 
scavenge free radicals and regulate oxidative 
defense mechanisms may have potential in the 
mitigation of cognitive dysfunction seen in 
neurodegenerative disorders. Indigofera tinctoria 
Linn. (I. tinctoria, Fabaceae) a traditional 
medicinal herb has been widely used for several 
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years in Indian and Chinese system of Medicine 
for the treatment of epilepsy, nervous disorders 
and liver ailments [9]. Experimental evidence 
suggests that I. tinctoria possesses anti-diabetic, 
anti-inflammatory, hepatoprotective, anti-
epileptic, anti-cancer and neuroprotective 
properties [9-11]. 
 
However, the cognitive-enhancing effect of I. 
tinctoria in amnesia conditions has not been 
studied. In the present study, we evaluated 
cognitive-enhancing effects of I. tinctoria extract 
in amnesia-induced experimental mice models. 
We also estimated the antioxidant defense 






Scopolamine butyl bromide (SBB), 2 deoxy-D-
ribose, thiobarbituric acid, nitro blue tetrazolium 
(NBT) and riboflavin were purchased from Sigma 
Chemical Company, St. Louis, MO, USA. All 
other chemicals used were of analytical grade. 
Stock solutions of all chemicals were prepared in 
distilled water and the dilutions were made fresh 
on the day of the experiment. 
 
Plant material and preparation of I. tinctoria 
extract 
 
Dried aerial part of I. tinctoria was obtained from 
Chemiloids, Vijayawada, India in the month of 
August 2008. The plant material was 
authenticated by Dr Vidyadar KN, a taxonomist 
at VJ’s College of Pharmacy and Research 
Institute, Rajahmundry, India and a voucher 
specimen (no. ITE-VJ/08) was deposited in 
Pharmacognosy Department Herbarium of the 
same institute. The plant material (1 kg) was 
powdered and extracted with boiling water (5 L) 
for 30 min using a Soxhlet apparatus. The filtrate 
was evaporated under vacuum at < 70 °C in a 
vacuum dryer to give a final yield of 74.12 g. The 
extract was dissolved in sterile distilled water, 
filtered through a 0.22 μm filter and stored at -20 




Swiss albino mice of either sex weighing 20 - 25 
g were obtained from the animal house of 
National Institute of Nutrition, Hyderabad, India. 
The animals were housed in an air conditioned 
animal room at 23 ± 2 oC with 12/12 h light/dark 
photoperiod, and given free access to food and 
water. The animals were kept for seven days in 
laboratory for habituation. All animal experiments 
were performed under the guidelines of 
Principles of Laboratory Animal Care (NIH 
publication no. 85-23, revised 1985) [12] and the 
Institutional Animal Care and Use Committee, 
Vishnu Institute of Pharmaceutical Education and 
Research, India (Reg no. 1358/ERe/S/10/ 
CPCSEA). 
 
Animal grouping and treatments 
 
The mice were divided into six groups (n = 15), 
i.e., vehicle, scopolamine (2 mg/kg), ITE (20 
mg/kg), scopolamine plus ITE (5 mg/kg), 
scopolamine plus ITE (10 mg/kg) and 
scopolamine plus ITE (20 mg/kg). Different 
doses of ITE were prepared freshly by dissolving 
in distilled water and administered for 15 days 
through oral gavage. Scopolamine was prepared 
in normal saline. On the 15th day, after 60 min of 
administration of doses, acquisition trail for 
passive avoidance and the transfer latency for 
elevated plus maze was recorded. On the next 
day, 60 min after administration of ITE at various 
doses, amnesia was induced by administration of 
scopolamine (2 mg/kg, i.p.) and animals were 
tested for their memory tests 30 min after 
scopolamine administration. For Y-maze, 
animals received scopolamine 30 min before 
performing the test.  
 
Passive avoidance test 
 
Experimental sessions were conducted using 
GEMINI active and passive avoidance system 
(San Diego Instruments, San Diego, CA, USA) 
connected to a computer as described earlier 
[13]. The instrument has a bright and a dark 
compartment with a computer-controlled 
guillotine door between them. Each animal was 
familiarized with the behavioral apparatus for 2-3 
min 24 h before the training session. The delivery 
of electric shocks, the raising and lowering of the 
door in the device were automatically controlled 
by the computer. On the day of training, animals 
were placed in dark compartment with heads 
facing the wall. After an acclimatization period of 
30 s the guillotine door automatically opens and 
the animal was subjected to a trial of 270 s. An 
entry into the dark compartment automatically 
shuts the door and the subject was punished with 
single low intensity foot shock of 0.5 mA for 5 s. 
The latency period at which the animals stepped 
into the dark from the bright compartment were 
recorded by the computer. The transfer from one 
compartment to another was recorded as 
transfer latency time (TLT) in seconds. The first 
trial is for acquisition and retention is tested by a 
second trial after 24 h. The shock is not delivered 
in the second trial. The criterion for learning was 
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taken as an increase in the TLT on second trial 




Immediate working memory performance was 
assessed by recording spontaneous alternation 
behavior during a single session in a Y-maze. 
Each arm was 40 cm long, 12 cm wide and 30 
cm high. The procedure was similar as described 
previously [13]. Each mouse, naïve to the maze, 
was placed at the end of one arm and allowed to 
move freely through the maze during an 8 m 
session, and arm entries were counted. The 
series of arm entries was recorded visually by 
person blinded to treatment group and arm entry 
was considered to be completed when hind paws 
of the mouse were completely placed in the arm. 
Alternation was defined as successive entries 
into the three arms, on overlapping triplet sets. 
Alternation was calculated as the ratio of actual 
to possible alternation (defined as the total 
number of arm entries minus two), expressed a 
percentage.  
 
Elevated plus maze test  
 
The elevated plus maze serves as exteroceptive 
behavioral model for evaluating learning and 
memory in mice. The apparatus consists of two 
open arms (16 cm × 5 cm) and two covered arms 
(16 cm × 5 cm × 12 cm). The arms extend from a 
central platform (5 cm × 5 cm), and the maze is 
elevated to a height of 25 cm from the floor. On 
the first day, each animal was placed at the end 
of an open arm, facing away from the central 
platform. Transfer latency (TL) was taken as the 
time taken by an animal to move into one of the 
covered arms with all its four legs. TL was 
recorded on the first day. If the animal did not 
enter into one of the covered arms within 90 s, it 
was gently pushed into one of the two covered 
arms, and TL was assigned as 90 s. The animal 
was allowed to explore the maze for 10 s and 
was then returned to its home cage. Memory 
retention was examined 24 h after the first day 
trial [14].  
 
Lipid peroxidation inhibition assay 
 
Swiss albino mice of either sex weighing 
between 20 - 25 g were sacrificed by spinal 
traction. Whole brain were excised and washed 
in ice-cold Tris- HCl buffer (0.1 M, pH 7.4), and 
cytosolic samples of liver and brain homogenate 
were prepared separately by using a tissue 
grinder (Thomas Scientific, NJ, USA) and 
centrifuging at 10,000 rpm for 30 min at 4 °C. 
The thiobarbituric acid substance (TBARS) assay 
was performed as described previously [15]. The 
reaction mixture (0.5 mL) containing mice brain 
homogenate (0.1 mL, 25 % w/v) in Tris-HCl 
buffer (40 mM, pH 7.0), KCl (30 mM), ferrous ion 
(0.16 mM), and ascorbic acid (0.06 mM) was 
incubated for 1 h at 37 °C in the presence and 
absence of various dilutions of ITE (1, 5, 10, 15 
and 20 μg). 
 
The incubation mixtures (0.4 mL) were treated 
with sodium dodecyl sulfate (8.1 %, 0.2 mL), 
thiobarbituric acid (0.8 %, 1.5 mL), and acetic 
acid (20 %, 1.5 mL, pH 3.5). The total volume 
was then made up to 4 mL with distilled water 
and kept in a water bath at 100 °C for 1 h. On 
cooling, 1 mL of distilled water and 5 mL of a 
mixture of n-butanol and pyridine (15:1 v/v) were 
added and vortexed. After centrifugation, the 
absorbance of the organic layer was measured 
spectrophotometrically at 532 nm (model UV-
1601, Shimadzu). Inhibition of lipid peroxidation 
was determined by comparing the results of the 
test compound with those of the control, and 
expressed as a percentage. The 50 % inhibition 
values were derived from a plot of ITE (μg) 
against absorbance.  
 
Superoxide radical assay 
 
Superoxide scavenging activity of ITE was 
determined by the method described previously 
[15], which depends on light induced superoxide 
generation by riboflavin and the corresponding 
reduction of nitro blue tetrazolium (NBT). The 
assay mixture contained different concentrations 
of ITE (1, 5, 10, 15 and 20 μg) and EDTA (6 µM 
containing 3 µg NaCN), NBT (50 µM), riboflavin 
(2 µM) and phosphate buffer (58 mM, pH 7.8) to 
give a total volume of 3 mL. The tubes were 
uniformly illuminated for 15 min and thereafter 
the optical density (O.D) was measured at 560 
nm using an UV Spectrophotometer (Shimadzu: 
UV- 1601). The 50 % inhibition values were 
derived from a plot of ITE tested (μg) against 
absorbance.  
 
Hydroxyl radical assay 
 
Hydroxyl radical scavenging activity was 
measured by studying the competition between 
deoxyribose and the extracts for hydroxyl 
radicals generated from the 
Fe3+/ascorbate/EDTA/H2O2 system (Fenton 
reaction). The hydroxyl radical attacks 
deoxyribose which eventually results in TBARS 
formation. Briefly, the reaction mixture contains 
deoxyribose (2.8 mM), ferric chloride(0.1 mM), 
EDTA (0.1 mM), H2O2 (1 mM), ascorbic acid (0.1 
mM), phosphate buffer (20 mM, pH 7.4) and 
various dilutions of ITE (1, 5, 10, 15 and 20 μg) 
in a final volume of 1 mL. The reaction was 
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incubated for 1 h at 37 °C. Deoxyribose 
degradation was measured as TBARS by the 
method described earlier [15]. The 50 % 
inhibition values were derived from a plot of ITE 
(μg) against absorbance.  
 
Statistical analysis  
 
The results are expressed as mean ± SEM. 
Statistical analysis was performed with SAS 
statistical software (SAS Institute, Cray, NC, 
USA) using one-way analysis of variance, 
followed by Dunnett's multiple range tests. P < 




Effect of ITE on scopolamine-induced passive 
avoidance task in mice 
 
As shown in Fig. 1, TLT was significantly 
increased on the second trial (221.5 ± 16.9 s) 
when compared with first trial (15.9 ± 1.3 s) in 
control-trained group, but in scopolamine-treated 
group there was no significant increase on 
second trial (17.05 ± 3.01 s) when compared with 
first trial (18.21 ± 3.4 s). ITE treated alone group 
(20 mg/kg) did not influence the TLT and was 
similar to control group. Pre-treatment with 
different doses of ITE (5, 10 and 20 mg/kg) for 15 
days increased the TLT on second trial (105.52 ± 
30.17 s for 5 mg/kg, 154.23 ± 16.72 s for 10 
mg/kg and 185.46 ± 22.62 s for 20 mg/kg) when 
compared with first trial (21.82 ± 6.3 s, 20.2 ± 3.3 
s and 23.81 ± 11.51 s), respectively in amnesic 
mice. The data indicate a dose-dependent effect, 
with 20 mg/kg showing the highest activity. There 
was no significant difference in TLT in the first 
trial among various groups. 
 
Effect of ITE on scopolamine-induced Y-maze 
task in mice 
 
As shown in Fig 2A, there was no significant 
difference observed in total arm entry of any 
group. However, administration of scopolamine 
(2 mg/kg, i.p) significantly (p < 0.001) decreased 
the percentage alternation (26.12 ± 1.35 s) when 
tested 30 min after the administration in mice Fig 
2B). Pre-treatment with ITE at indicated (5, 10 
and 20 mg/kg, p.o.) ameliorated the 
scopolamine-induced decreased percentage 
alternation in mice significantly (p < 0.05 at 5 and 
10 mg/kg and p < 0.01 at 20 mg/kg). Results 
indicated that ITE exhibited a dose dependent 
activity with 20 mg/kg exhibiting the highest 
effect (49. 42 ± 0.95 s). 
 
Figure 1: Effect of ITE on scopolamine-induced amnesia in passive avoidance test. Memory impairment was 
induced by scopolamine (2 mg/kg, i.p.) 5 min before acquisition (Trial I), and retention (Trial II) was carried out 24 
h after scopolamine treatment. □: Acquisition, ■: Retention. #p < 0.001 compared with control group. NS: Not 
significant. *p < 0.05, **p<0.01 and ***p < 0.001 compared with scopolamine group. Data is expressed as mean ± 
S.E.M. (n = 5) using one-way ANOVA followed by Tuckey’s Multiple comparison test in the Graph Pad Prism 
v5.01 software. SBB: Scopolamine butyl bromide; ITE: I. tinctoria aqueous extract 
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Figure 2: Effect of ITE on scopolamine-induced 
memory deficits in the Y-maze test. Spatial working 
memory was assessed using Y- Maze. Memory 
impairment was induced by scopolamine treatment (2 
mg/kg, i.p.), and the test was carried out 30 min later. 
Total Arm entry (A) and percentage alternation (B) 
was evaluated. #p < 0.001 compared with control 
group. NS: Not significant. *p < 0.05 and **p < 0.01 
compared with scopolamine group. Data is expressed 
as mean ± SEM (n = 5) using one-way ANOVA 
followed by Tuckey’s Multiple comparison test in the 
Graph Pad Prism v5.01 software. SBB: Scopolamine 
butyl bromide; ITE: I. tinctoria aqueous extract 
 
Effect of ITE on scopolamine-induced 
elevated plus maze test in mice 
 
The scopolamine treated group showed a 
significant increase (p < 0.05) in transfer latency 
values in the acquisition (153.12 ± 10.82 s) as 
well as the retention period (127.64 ± 8.24 s) 
over those of the vehicle control mice, indicating 
impairment in learning and memory (Fig. 3). Pre-
treatment with ITE at various doses (5, 10 and 20 
mg/kg) for 15 days improved the memory in the 
elevated plus maze. ITE administration dose-
dependently (p < 0.5, p < 0.01 and p < 0.001 at 
5, 10 and 20 mg/mL respectively), caused a 
significant reduction in the acquisition and 
retention latency in scopolamine-treated group 
with 20 mg/mL showing the highest effect 
(acquisition, 75.62 ± 5.21 s and retention, 69.23 
± 4.21 s). 
 
Effect of ITE on lipid peroxidation, superoxide 
and hydroxyl radical inhibition 
 
ITE at various concentrations (1, 5, 10 and 20 
μg) inhibited the lipid peroxide, superoxide and 
hydroxyl radicals in a dose-dependent manner 
(Fig. 4). The quantity of ITE (μg) needed for 50 
% inhibition was 7.28 ± 0.3, 7.62 ± 0.4 and 5.25 
± 0.4μg/mL, respectively (Fig 4A - C). 
 
Figure 3: Effect of ITE on scopolamine-induced memory impairment in mice using the elevated plus maze test. 
Transfer latency in seconds was measured in first trial second trial. □: Acquisition, ■: Retention. #p < 0.001 
compared with control group. NS: Not significant. *p<0.05 and **p<0.01 compared with scopolamine group. Data 
is expressed as mean ± S.E.M. (n=5) using one-way ANOVA followed by Tuckey’s Multiple comparison test in 
the Graph Pad Prism v5.01 software. SBB: Scopolamine butyl bromide; ITE: I. tinctoria aqueous extract 
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Figure 4: Effect of ITE on the inhibition of free 
radicals. A: Lipid peroxidation inhibition, B: Superoxide 
radical inhibition and C: Hydroxyl radical inhibition. 
(n=6). The dotted lines indicate the concentration 





In the present investigation ITE showed 
significant inhibition of cognitive deficits observed 
in scopolamine-induced amnesic mice. 
Furthermore, the extract exhibited potent 
antioxidant action by inhibiting lipid peroxide, 
superoxide and hydroxyl radicals. Cognitive 
impairment is one of the major health problems 
and a characteristic symptom of several 
neurodegenerative disorders including 
Alzheimer’s disease (AD) and Parkinson’s 
disease (PD) [16]. Mounting evidence suggests 
that oxidative stress and free radicals might play 
a critical role in the process of cognitive 
impairments [17,18]. It is well documented that 
scopolamine induction impairs retrieval of 
memory in experimental animals and such 
amnesia is associated with a significant increase 
in oxidative stress [17]. Therefore, scopolamine-
induced amnesia could be used as a valid model 
to study the role of antioxidant defense 
mechanisms in cognitive dysfunctions.  
 
In the present study, the findings from passive 
avoidance test suggest that ITE at various doses 
(5, 10 and 20 mg/kg) showed increase in TLT in 
retention trial of passive avoidance. Further, 
cognitive behavior evaluated through Y-maze 
test suggests an improvement in percentage 
alteration behavior in ITE treated groups against 
scopolamine-induced amnesia in a dose-
dependent manner. Furthermore, elevated plus 
maze test revealed that ITE showed protective 
effect in TL against scopolamine-induced 
amnesia dose-dependently. Moreover, the 
decrease in TL during retention period indicate 
the positive response of ITE in attenuating 
learning and memory deficits induced by 
scopolamine. 
 
The major active constituents of I. tinctoria are 
the flavonoids, terpenoids, alkaloids, glycosides, 
methyl paraben, indigotine and indiruben [19]. 
Some of these constituents are well reported to 
possess antioxidant effects [20]. Further, it has 
been demonstrated that certain phenolic 
antioxidants form I. tinctoria attenuate neuronal 
cell death induced by oxidative stress in mouse 
PD models exhibiting neuroprotective properties 
based on antioxidant defense mechanisms 
[9,18]. In the present study, ITE scavenged the 
free radicals such as lipid peroxide, superoxide 
and hydroxyl radical indicating their usefulness in 
oxidative stress-related cognitive dysfunctions. 
Importantly, ITE scavenged the lipid peroxides in 
a concentration-dependent manner in brain 
homogenates of mice indicating that ITE might 





This study provides scientific support for the use 
of ITE in alleviating cognitive deficits induced by 
scopolamine in mice which might be due to its 
antioxidant action. Based on these present 
results and some traditional medicinal claims, 
ITE may be developed as a potential therapeutic 
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agent in attenuating cognitive dysfunctions seen 
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